SCHEMBL15468352

SCHEMBL15468352

CCOC(=O)CC(C)c1ccc(NC(=O)C(C)Oc2cccc(C(C)C)c2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.47
MEN1 O00255 3/20 0.47
MAPT P10636 3/20 0.47
ALDH1A1 P00352 2/20 0.46
LMNA P02545 3/20 0.45
RXFP1 Q9HBX9 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
TSHR P16473 2/20 0.44
POLB P06746 1/20 0.44
MAPK1 P28482 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
ATM Q13315 1/20 0.43
CRHBP P24387 1/20 0.43
CRHR2 Q13324 1/20 0.43
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
HTT P42858 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3162742 0.87 KMT2A (0.51) KMT2AMEN1MAPTALDH1A1LMNA
SCHEMBL230566 0.86 FFAR1 (0.43) KMT2AMEN1MAPTALDH1A1LMNA
SCHEMBL10064814 0.78 KMT2A (0.51) KMT2AMEN1ALDH1A1LMNARXFP1
SCHEMBL3106053 0.77 HSD11B1 (0.44) KMT2AMEN1MAPTALDH1A1LMNA
SCHEMBL10065685 0.76 KMT2A (0.64) KMT2AMEN1MAPTALDH1A1LMNA
SCHEMBL231688 0.75 FFAR1 (0.54) TSHRHTT
SCHEMBL10064815 0.75 KMT2A (0.64) KMT2AMEN1MAPTALDH1A1RXFP1
SCHEMBL21199753 0.74 ALDH1A1 (0.50) KMT2AMEN1MAPTALDH1A1LMNA
SCHEMBL4115797 0.74 L3MBTL1 (0.52) MAPTALDH1A1L3MBTL1TSHRMAPK1
SCHEMBL10065062 0.73 FFAR1 (0.62) KMT2AMEN1MAPTALDH1A1RXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8648038-B2 (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments SANOFI (FR) 2014-02-11 US disclosed
US-20120004167-A1 (2-ARYLOXYACETYLAMINO) PHENYLPROPIONIC ACID DERIVATIVES, PROCESSES FOR PREPARATION THEREOF AND USE THEREOF AS MEDICAMENTS SANOFI (FR) 2012-01-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120004167-A1 (2-ARYLOXYACETYLAMINO) PHENYLPROPIONIC ACID DERIVATIVES, PROCESSES FOR PREPARATION THEREOF AND USE THEREOF AS MEDICAMENTS GPR119, DPP9, DPP7 KMT2A 3285/4885MEN1 2368/4885MAPT 4470/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.